Cargando…
Autoimmune Hemolytic Anemia Secondary to COVID-19 Vaccine: A Case Report
Autoimmune hemolytic anemia (AIHA) is an acquired hemolysis caused by one's immune system targeting red blood cell surface antigens, resulting in a shortening of the normal red-cell lifespan of 120 days. In this case report, we present an unusual case of a middle-aged woman with no known autoim...
Autores principales: | Chaudhary, Mitul H, Yennam, Anil Kumar, Bojanki, Nagavenakata Lova Surya Vamshi Avinash, Dela Cruz, Alyssa Nicole G, Chaudhary, Nirali K, Kinha, Hitesh, Annepu, Yoshita Rao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628599/ https://www.ncbi.nlm.nih.gov/pubmed/37942375 http://dx.doi.org/10.7759/cureus.46678 |
Ejemplares similares
-
Autoimmune hemolytic anemia: From lab to bedside
por: Chaudhary, R. K., et al.
Publicado: (2014) -
Acquired Amegakaryocytic Thrombocytopenia Associated With Autoimmune Hemolytic Anemia
por: Ikeda, Naoto, et al.
Publicado: (2022) -
Warm and Cold Autoimmune Hemolytic Anemia in the Setting of COVID-19 Disease
por: Brazel, Danielle, et al.
Publicado: (2021) -
A Unique Triad: Ulcerative Colitis, Primary Sclerosing Cholangitis, and Autoimmune Hemolytic Anemia
por: Naqvi, Syeda, et al.
Publicado: (2018) -
A Case of Warm Autoimmune Hemolytic Anemia Secondary to Epstein-Barr Virus Infection
por: Abidoye, Oluseyi, et al.
Publicado: (2022)